SCHEMBL17322909

SCHEMBL17322909

CC(F)(F)Cn1nc(-c2ccccc2)c2ccccc21

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSD17B10 Q99714 2/20 0.56
ALDH1A1 P00352 4/20 0.53
KDM4E B2RXH2 2/20 0.53
KMT2A Q03164 2/20 0.53
SMN1; SMN2 Q16637 2/20 0.53
LMNA P02545 2/20 0.53
HTT P42858 2/20 0.53
HPGD P15428 1/20 0.53
TSHR P16473 2/20 0.51
F2RL3 Q96RI0 1/20 0.43
ALOX15 P16050 1/20 0.42
RORC P51449 3/20 0.41
PDE5A O76074 1/20 0.40
ESR1 P03372 1/20 0.40
MAPT P10636 1/20 0.39
NPSR1 Q6W5P4 2/20 0.39
CYP1A2 P05177 1/20 0.39
CYP3A4 P08684 1/20 0.39
CYP2D6 P10635 1/20 0.39
CYP2C9 P11712 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17326656 0.88 HSD17B10 (0.59) HSD17B10ALDH1A1KDM4EKMT2ASMN1; SMN2
SCHEMBL17322911 0.79 HSD17B10 (0.64) HSD17B10ALDH1A1KDM4EKMT2ASMN1; SMN2
SCHEMBL30339906 0.78 KMT2A (0.53) HSD17B10ALDH1A1KDM4EKMT2ASMN1; SMN2
SCHEMBL30340038 0.77 KMT2A (0.52) HSD17B10ALDH1A1KDM4EKMT2ASMN1; SMN2
SCHEMBL30339641 0.76 KMT2A (0.51) HSD17B10ALDH1A1KDM4EKMT2ASMN1; SMN2
SCHEMBL17322906 0.76 ALDH1A1 (0.57) HSD17B10ALDH1A1KDM4EKMT2ASMN1; SMN2
SCHEMBL11834058 0.76 HSD17B10 (0.69) HSD17B10ALDH1A1KDM4EKMT2ASMN1; SMN2
SCHEMBL17326655 0.75 HSD17B10 (0.59) HSD17B10ALDH1A1KDM4EKMT2ASMN1; SMN2
SCHEMBL17028033 0.74 PTGER4 (0.54) HSD17B10ALDH1A1KDM4EKMT2ASMN1; SMN2
SCHEMBL30495303 0.74 PTGER4 (0.54) HSD17B10ALDH1A1KDM4EKMT2ASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9738610-B2 Indazole derivatives and uses thereof WHITEHEAD INSTITUTE FOR BIOMEDICAL RESEARCH (US) 2017-08-22 US disclosed
US-20150353503-A1 INDAZOLE DERIVATIVES AND USES THEREOF WHITEHEAD INSTITUTE FOR BIOMEDICAL RESEARCH (US) 2015-12-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150353503-A1 INDAZOLE DERIVATIVES AND USES THEREOF CYP11B1, HSP90B1, CYP1B1 HSD17B10 258/4885ALDH1A1 1340/4885KDM4E 4525/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.